Tokyo, Japan

Kosuke Takada

This inventor holds 3 USPTO granted patents. Top assignees: The University of Tokyo, Wisconsin Alumni Research Foundation, Agc Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kosuke Takada. Retrieved from https://idiyas.com/inventor/kosuke-takada-p6ium0rd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kosuke Takada: Innovator in Influenza Research

Introduction

Kosuke Takada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of influenza research, particularly through his innovative patents. With a total of 3 patents, Takada's work focuses on enhancing the understanding and treatment of influenza viruses.

Latest Patents

One of Takada's latest patents involves the development of a humanized cell line. This mammalian or avian cell line expresses high levels of human influenza virus receptors. In one embodiment, the cell line supports human influenza virus, such as the human A/H3 influenza virus, isolation and growth much more effectively than conventional (unmodified) cells. The propagated viruses may maintain higher genetic stability than in corresponding cells, showcasing the potential for improved research and treatment options.

Career Highlights

Throughout his career, Takada has worked with esteemed institutions, including the Wisconsin Alumni Research Foundation and the University of Tokyo. His research has been pivotal in advancing the understanding of influenza viruses and their interactions with human cells.

Collaborations

Takada has collaborated with notable researchers in the field, including Yoshihiro Kawaoka and Masaki Imai. These collaborations have further enriched his research and contributed to the scientific community's knowledge of influenza.

Conclusion

Kosuke Takada's innovative work in developing humanized cell lines has the potential to significantly impact influenza research and treatment. His contributions continue to pave the way for advancements in the field, making him a key figure in the ongoing battle against influenza viruses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…